XML 71 R62.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity (Details) - USD ($)
 1 Months Ended 6 Months Ended 12 Months Ended
Apr. 30, 2021
Mar. 31, 2019
Dec. 31, 2017
Jul. 31, 2017
Oct. 31, 2016
Feb. 29, 2016
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Jun. 10, 2020
Jun. 14, 2018
Jun. 30, 2010
Stockholders' Equity (Details) [Line Items]                          
Gross proceeds (in Dollars) $ 4,233,026 $ 9,000,002 $ 3,049,991     $ 5,900,003              
Common stock shares sold 515,156 1,636,364 417,807     1,123,810              
Sale of stock, per share (in Dollars per share) $ 8.25 $ 5.5 $ 7.3     $ 5.25              
Net proceeds (in Dollars) $ 4,250,038 $ 8,303,436 $ 2,734,173     $ 5,313,224              
Exercised stock options covering shares               5,000          
Stock options covering cash (in Dollars)               $ 30,672          
Option outstanding of exercise price (in Dollars per share)             $ 6.82   $ 7.19 $ 6.94      
Exercise prices per share (in Dollars per share)             5.19   $ 7.73        
Common stock purchase price (in Dollars per share)             $ 70            
Exercisable and transferable, description             The Rights (as amended) become exercisable and transferable apart from the common stock upon the earlier of i) 10 days following a public announcement that a person or group (Acquiring Person) has, without the prior consent of the Continuing Directors (as such term is defined in the Rights Agreement), acquired beneficial ownership of 20% or more of the outstanding common stock or ii) 10 days following commencement of a tender offer or exchange offer the consummation of which would result in ownership by a person or group of 20% or more of the outstanding common stock (the earlier of such dates being called the Distribution Date).            
Purchase price (in Dollars per share)             $ 70            
Common stock were changed percentage             50.00%            
Price per Right (in Dollars per share)             $ 0.005            
Extend the rights plan, description             Our Board of Directors decided to seek an advisory vote by stockholders at the Annual Meeting of Stockholders held in June 2022, as to whether to extend the Rights Plan by one year to September 19, 2023. Of the votes actually cast on this proposal, 65% voted in favor, 32% voted against and 3% abstained. On the basis of this vote, our Board of Directors voted to extend the Rights Plan by one year to September 19, 2023. Our Board of Directors decided to seek another advisory vote by stockholders at the Annual Meeting of Stockholders held in June 2023, as to whether to extend the Rights Plan by another year to September 19, 2024. Of the votes actually cast on this proposal, 65.10% voted in favor, 34.60% voted against and 0.30% abstained. On the basis of this vote, our Board of Directors voted to extend the Rights Plan by one year to September 19, 2024. Recognizing that there might be a substantial number of broker non-votes, our Board of Directors disclosed that it would be guided by the votes actually cast on these proposals in deciding whether to extend the expiration date of such plan by one year.            
Common stock, shares authorized             15,000,000   15,000,000        
2010 Plan [Member]                          
Stockholders' Equity (Details) [Line Items]                          
Common stock outstanding under the plan             202,500   202,500       300,000
Stock option expiration period             10 years            
Weighted average remaining life of options outstanding             6 years            
Weighted average remaining life of options exercisable             3 years            
Stock options granted             108,000            
2017 Plan [Member]                          
Stockholders' Equity (Details) [Line Items]                          
Common stock outstanding under the plan             421,500   402,500        
Stock option expiration period             10 years            
Weighted average remaining life of options exercisable             9 months            
2017 Plan [Member] | Common Stock [Member]                          
Stockholders' Equity (Details) [Line Items]                          
Shares of common stock             300,000            
Minimum [Member]                          
Stockholders' Equity (Details) [Line Items]                          
Exercise prices per share (in Dollars per share)             $ 5.11            
Percentage of acquiring person             20.00%            
Common stock, shares authorized                     11,000,000 8,000,000  
Minimum [Member] | 2010 Plan [Member]                          
Stockholders' Equity (Details) [Line Items]                          
Option outstanding of exercise price (in Dollars per share)             $ 4            
Minimum [Member] | 2017 Plan [Member]                          
Stockholders' Equity (Details) [Line Items]                          
Shares of common stock               300,000          
Maximum [Member]                          
Stockholders' Equity (Details) [Line Items]                          
Exercise prices per share (in Dollars per share)             $ 5.22            
Percentage of acquiring person             20.00%            
Common stock, shares authorized                     15,000,000 11,000,000  
Maximum [Member] | 2010 Plan [Member]                          
Stockholders' Equity (Details) [Line Items]                          
Option outstanding of exercise price (in Dollars per share)             $ 10.04            
Maximum [Member] | 2017 Plan [Member]                          
Stockholders' Equity (Details) [Line Items]                          
Shares of common stock               650,000          
Private Placement [Member]                          
Stockholders' Equity (Details) [Line Items]                          
Gross proceeds (in Dollars)         $ 3,464,370                
Common stock shares sold         659,880                
Net proceeds (in Dollars)         $ 3,160,923                
Closing share price (in Dollars per share)         $ 5.25                
Acquiring Person [Member]                          
Stockholders' Equity (Details) [Line Items]                          
Acquisition percentage             50.00%            
Investor [Member]                          
Stockholders' Equity (Details) [Line Items]                          
Gross proceeds (in Dollars)       $ 1,050,000                  
Net proceeds (in Dollars)       $ 1,034,164                  
Closing share price (in Dollars per share)       $ 5.25                  
Common stock shares issued       200,000                  
February 2016 to April 2021 [Member]                          
Stockholders' Equity (Details) [Line Items]                          
Potential issuance or sale of equity (in Dollars)             $ 4,553,017            
Gross proceeds (in Dollars)             $ 26,714,403            
Weighted average price (in Dollars per share)             $ 5.87            
Employee Stock Option [Member]                          
Stockholders' Equity (Details) [Line Items]                          
Stock options granted (in Dollars per share)             $ 2.8 $ 4.37          
Share-based payment, description             As of June 30, 2023, total unrecognized stock-based compensation related to non-vested stock options aggregated $798,447, which will be recognized over a weighted average remaining period of approximately 2 years and 1 month.